Danaher Shares Surge 8% After Earnings Beat, Though Full-Year Outlook Slightly Trails Forecasts

Core Insights - Danaher Corporation's shares increased approximately 8% in intra-day trading following the release of third-quarter results that exceeded analyst expectations, despite full-year earnings guidance being slightly below consensus at the midpoint [1] - The company reported earnings per share of $1.89, surpassing the analyst estimate of $1.72, and revenue reached $6.05 billion, slightly above the $6 billion consensus forecast [1] Fiscal 2025 Projections - For fiscal 2025, Danaher projected earnings per share between $7.70 and $7.80, with a midpoint of $7.75, which is just under the analyst consensus of $7.78 [2] - Management anticipates non-GAAP core revenue growth to remain in the low single digits year-over-year [2] - Executives highlighted that advancements in bioprocessing and diagnostics, along with operational discipline, contributed to the strong quarterly results [2]